This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toffoli, G. Articles by Boiocchi, M. Search for Related Content PubMed PubMed Citation Articles by Toffoli, G. Articles by Boiocchi, M.

Methylenetetrahydrofolate Reductase 677 CT Polymorphism and Risk of Proximal Colon Cancer in North Italy¹

Experimental and Clinical Pharmacology Unit, Division of Experimental Oncology 1, Centro di Riferimento Oncologico, Aviano (PN) [G. T., R. D., F. S., M. L., A. V., M. B.]; Department of Experimental and Diagnostic Medicine, Ferrara [R. G., G. L.]; Department of Epidemiology Local Health Authority of Milan, Milan [A. R.]; and Department of Biomedical Science, Clinical Pathology and Molecular Oncology Section, University of Catania, Catania [M. L.] Italy

Purpose: Gene silencing by hypermethylation plays an important role in proximal colon carcinogenesis. Conversely, DNA hypomethylation has been associated with distal colon cancer (CLC). Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5',10'-methylenetetrahydrofolate to 5'-methyl tetrahydrofolate, which serves as methyl donor in the remethylation of homocysteine to methionine. A common MTHFR 677 CT polymorphism is characterized by reduced catalytic activity, which affects methionine synthesis and DNA methylation.

The aim of the study was to investigate the role of MTHFR 677 CT gene polymorphism in the tumorigenesis of proximal and distal CLC in a monoinstitutional group of patients in North Italy.

Experimental Design: One-hundred thirty four consecutive proximal and 142 consecutive distal CLC patients, and 279 control subjects without cancer were genotyped for MTHFR using PCR-restriction fragment-length polymorphism analysis.

Results: The prevalence of the 677 TT genotype was significantly (P = 0.005) lower in patients with proximal tumors (10 of 134, 7%) than in subjects with distal tumors (28 of 142, 20%). Case/control approach indicated that individuals homozygous for the 677 TT allele had a significantly reduced risk (2.8-fold) (adjusted odds ratio, 0.36; 95% confidence intervals, 0.14–0.91) of developing proximal CLC compared with those harboring the wild-type or heterozygous genotype (677 CC or 677 CT). No significant association between CLC risk and TT genotype was observed in patients with distal tumors (odds ratio, 1.01; 95% confidence interval, 0.48–2.14).

Conclusions: Our findings support a role for MTHFR 677 TT genotype in reducing proximal CLC risk in North Italy.

This article has been cited by other articles:

				T. Vaissiere, R. J. Hung, D. Zaridze, A. Moukeria, C. Cuenin, V. Fasolo, G. Ferro, A. Paliwal, P. Hainaut, P. Brennan, et al. Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors Cancer Res., January 1, 2009; 69(1): 243 - 252. [Abstract] [Full Text] [PDF]

				M. Pande, J. Chen, C. I. Amos, P. M. Lynch, R. Broaddus, and M. L. Frazier Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms C677T and A1298C on Age-Associated Risk for Colorectal Cancer in a Caucasian Lynch Syndrome Population Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1753 - 1759. [Abstract] [Full Text] [PDF]

				R. A. Hubner, S. Lubbe, I. Chandler, and R. S. Houlston MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer Hum. Mol. Genet., May 1, 2007; 16(9): 1072 - 1077. [Abstract] [Full Text] [PDF]

				A. Koushik, P. Kraft, C. S. Fuchs, S. E. Hankinson, W. C. Willett, E. L. Giovannucci, and D. J. Hunter Nonsynonymous Polymorphisms in Genes in the One-Carbon Metabolism Pathway and Associations with Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2408 - 2417. [Abstract] [Full Text] [PDF]

				K. Matsuo, H. Ito, K. Wakai, K. Hirose, T. Saito, T. Suzuki, T. Kato, T. Hirai, Y. Kanemitsu, H. Hamajima, et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan Carcinogenesis, December 1, 2005; 26(12): 2164 - 2171. [Abstract] [Full Text] [PDF]

				A. M. Eaton, R. Sandler, J. M. Carethers, R. C. Millikan, J. Galanko, and T. O. Keku 5,10-Methylenetetrahydrofolate Reductase 677 and 1298 Polymorphisms, Folate Intake, and Microsatellite Instability in Colon Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2023 - 2029. [Abstract] [Full Text] [PDF]

				Q. Shi, Z. Zhang, G. Li, P. C. Pillow, L. M. Hernandez, M. R. Spitz, and Q. Wei Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1477 - 1484. [Abstract] [Full Text] [PDF]

				M Pufulete, R Al-Ghnaniem, A Khushal, P Appleby, N Harris, S Gout, P W Emery, and T A B Sanders Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma Gut, May 1, 2005; 54(5): 648 - 653. [Abstract] [Full Text] [PDF]

				H. Yamamoto, H. Hanafusa, M. Ouchida, M. Yano, H. Suzuki, M. Murakami, M. Aoe, N. Shimizu, K. Nakachi, and K. Shimizu Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population Carcinogenesis, February 1, 2005; 26(2): 411 - 416. [Abstract] [Full Text] [PDF]

				K. Kawakami, A. Ruszkiewicz, G. Bennett, J. Moore, G. Watanabe, and B. Iacopetta The Folate Pool in Colorectal Cancers Is Associated with DNA Hypermethylation and with a Polymorphism in Methylenetetrahydrofolate Reductase Clin. Cancer Res., December 1, 2003; 9(16): 5860 - 5865. [Abstract] [Full Text] [PDF]